2-acetylamino-3-chloro-1,4-naphthoquinone and thromboxane a2

2-acetylamino-3-chloro-1,4-naphthoquinone has been researched along with thromboxane a2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CH; Chung, CH; Hsu, CC; Huang, TF; Kuo, HL; Kuo, SC; Lien, JC; Peng, HC	1

Other Studies

1 other study(ies) available for 2-acetylamino-3-chloro-1,4-naphthoquinone and thromboxane a2

Article	Year
NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry. British journal of pharmacology, 2011, Volume: 162, Issue:8 Topics: Animals; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Fibrinolytic Agents; Male; Mice; Mice, Inbred ICR; Naphthoquinones; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2	2011

Article

Year

NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry.

British journal of pharmacology, 2011, Volume: 162, Issue:8

Topics: Animals; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Fibrinolytic Agents; Male; Mice; Mice, Inbred ICR; Naphthoquinones; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2

2011